基本信息
浏览量:4
职业迁徙
个人简介
Dr Luwor has almost two decades experience in using human cancer models and human patient samples to investigate the genetic and molecular alterations associated with cancer. Further to this Dr Luwor has expertise in developing molecular therapeutics for inhibition of tumour growth and progression.
In particular, Dr Luwor has performed pre-clinical, therapeutic evaluation of several agents designed to block tumour growth. More recently, Dr Luwor has expanded his research interests to explore tumour resistance to both molecular targeted therapy and standard chemotherapy.
In particular, Dr Luwor has performed pre-clinical, therapeutic evaluation of several agents designed to block tumour growth. More recently, Dr Luwor has expanded his research interests to explore tumour resistance to both molecular targeted therapy and standard chemotherapy.
研究兴趣
论文共 105 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Molecular immunology (2024): 101-109
Ayenachew Bezawork-Geleta, Diane Moujalled,David P De Souza,Vinod K Narayana, James Dimou,Rodney Luwor,Matthew J Watt
Metabolitesno. 8 (2024)
Sarah F. Stuart, Peter Curpen, Adele J. Gomes, Michelle C. Lan,Shuai Nie,Nicholas A. Williamson, George Kannourakis,Andrew P. Morokoff,Adrian A. Achuthan,Rodney B. Luwor
Brain sciencesno. 1 (2024): 89-89
Integrative cancer therapies (2024): 15347354241243024-15347354241243024
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2024)
Cellsno. 2 (2024): 192-192
Sarah F. Stuart, Ayenachew Bezawork-Geleta, Zammam Areeb, Juliana Gomez, Vanessa Tsui, Ahmad Zulkifli, Lucia Paradiso, Jordan Jones, Hong P. T. Nguyen, Tracy L. Putoczki, Paul V. Licciardi, George Kannourakis, Andrew P. Morokoff, Adrian A. Achuthan,Rodney B. Luwor
International Journal of Molecular Sciencesno. 4 (2023): 3356
加载更多
作者统计
#Papers: 105
#Citation: 4764
H-Index: 35
G-Index: 68
Sociability: 6
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn